Taysha Gene Therapies
TSHA
TSHA
54 hedge funds and large institutions have $27M invested in Taysha Gene Therapies in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
54
Holding in Top 10
–
Calls
$191K
Puts
–
Top Buyers
| 1 | +$138K | |
| 2 | +$133K | |
| 3 | +$95.9K | |
| 4 |
CC
Carlson Capital
Dallas,
Texas
|
+$67.5K |
| 5 |
CIC
Cornercap Investment Counsel
Atlanta,
Georgia
|
+$28.2K |
Top Sellers
| 1 | -$453K | |
| 2 | -$341K | |
| 3 | -$203K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$169K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$148K |